Table 1 Weekly self-reported adverse events
From: Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study
Adverse events | Number of patients (%) |
|---|---|
Fatigue | 5 (55.6) |
Rash | 4 (44.4) |
Anorexia | 4 (44.4) |
Cough | 4 (44.4) |
Headache | 3 (33.3) |
Insomnia | 3 (33.3) |
Dizziness | 3 (33.3) |
Nausea | 3 (33.3) |
Dyspepsia | 3 (33.3) |
Decrease in weight | 2 (22.2) |
Flatulence | 1 (11.1) |